Cargando…

Increased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in Tunisia

INTRODUCTION: Previous studies have highlighted the importance of polymorphisms of toll-like receptors (TLRs) in the pathogenesis of certain cancers, including head and neck cancers (HNC). AIM OF THE STUDY: The aim of this study was to evaluate the association of TLR2 (-196 to -174 ins/del) and TLR3...

Descripción completa

Detalles Bibliográficos
Autores principales: Makni, Lamia, Zidi, Sabrina, Barbiroud, Mouadh, Ahmed, Amira Ben, Gazouani, Ezzedine, Mezlini, Amel, Stayoussef, Mouna, Yacoubi-Loueslati, Besma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Society of Experimental and Clinical Immunology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745549/
https://www.ncbi.nlm.nih.gov/pubmed/31530984
http://dx.doi.org/10.5114/ceji.2019.87065
_version_ 1783451565166690304
author Makni, Lamia
Zidi, Sabrina
Barbiroud, Mouadh
Ahmed, Amira Ben
Gazouani, Ezzedine
Mezlini, Amel
Stayoussef, Mouna
Yacoubi-Loueslati, Besma
author_facet Makni, Lamia
Zidi, Sabrina
Barbiroud, Mouadh
Ahmed, Amira Ben
Gazouani, Ezzedine
Mezlini, Amel
Stayoussef, Mouna
Yacoubi-Loueslati, Besma
author_sort Makni, Lamia
collection PubMed
description INTRODUCTION: Previous studies have highlighted the importance of polymorphisms of toll-like receptors (TLRs) in the pathogenesis of certain cancers, including head and neck cancers (HNC). AIM OF THE STUDY: The aim of this study was to evaluate the association of TLR2 (-196 to -174 ins/del) and TLR3 (1377 C>T) as potential risk factors for HNC in Tunisians. MATERIAL AND METHODS: A case-control study including 246 HNC patients (174 nasopharyngeal carcinoma – NPC and 72 laryngeal cancer – LC) and 250 healthy controls. Genotyping was done by using PCR and PCR-RFLP methods. RESULTS: Higher minor allele frequencies of TLR2 (-196 to -174 ins/del) and TLR3 1377 C>T polymorphisms were seen in HNC, NPC, and LC compared to controls. In addition, higher increased HNC, NPC, and LC risk was associated with TLR2 ins/del and TLR2 del/del genotypes (p < 0.0001). Positive association with HNC, NPC, and LC risk was seen with TLR2 del-containing genotypes (ins/del + del/del) (p < 0.0001). The T/T genotype of TLR3 is associated with HNC, NPC, and LC susceptibility (p < 0.0001). Positive association with HNC and NPC risk was seen with TLR3 T allele carriers (C/T + T/T) (p < 0.0001). Increased frequency of T-ins, C-del, and T-del haplotypes was revealed in HNC and NPC cases than healthy controls; however, T-del was significantly higher in LC cases. CONCLUSIONS: Our results demonstrate an increased risk of HNC, NPC, and LC with TLR2 ins/del, TLR2 del/del, and TLR3 T/T genotypes. And positive association with T-ins, C-del, and T-del haplotypes with HNC and NPC and T-del haplotype with LC.
format Online
Article
Text
id pubmed-6745549
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Polish Society of Experimental and Clinical Immunology
record_format MEDLINE/PubMed
spelling pubmed-67455492019-09-17 Increased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in Tunisia Makni, Lamia Zidi, Sabrina Barbiroud, Mouadh Ahmed, Amira Ben Gazouani, Ezzedine Mezlini, Amel Stayoussef, Mouna Yacoubi-Loueslati, Besma Cent Eur J Immunol Clinical Immunology INTRODUCTION: Previous studies have highlighted the importance of polymorphisms of toll-like receptors (TLRs) in the pathogenesis of certain cancers, including head and neck cancers (HNC). AIM OF THE STUDY: The aim of this study was to evaluate the association of TLR2 (-196 to -174 ins/del) and TLR3 (1377 C>T) as potential risk factors for HNC in Tunisians. MATERIAL AND METHODS: A case-control study including 246 HNC patients (174 nasopharyngeal carcinoma – NPC and 72 laryngeal cancer – LC) and 250 healthy controls. Genotyping was done by using PCR and PCR-RFLP methods. RESULTS: Higher minor allele frequencies of TLR2 (-196 to -174 ins/del) and TLR3 1377 C>T polymorphisms were seen in HNC, NPC, and LC compared to controls. In addition, higher increased HNC, NPC, and LC risk was associated with TLR2 ins/del and TLR2 del/del genotypes (p < 0.0001). Positive association with HNC, NPC, and LC risk was seen with TLR2 del-containing genotypes (ins/del + del/del) (p < 0.0001). The T/T genotype of TLR3 is associated with HNC, NPC, and LC susceptibility (p < 0.0001). Positive association with HNC and NPC risk was seen with TLR3 T allele carriers (C/T + T/T) (p < 0.0001). Increased frequency of T-ins, C-del, and T-del haplotypes was revealed in HNC and NPC cases than healthy controls; however, T-del was significantly higher in LC cases. CONCLUSIONS: Our results demonstrate an increased risk of HNC, NPC, and LC with TLR2 ins/del, TLR2 del/del, and TLR3 T/T genotypes. And positive association with T-ins, C-del, and T-del haplotypes with HNC and NPC and T-del haplotype with LC. Polish Society of Experimental and Clinical Immunology 2019-07-30 2019 /pmc/articles/PMC6745549/ /pubmed/31530984 http://dx.doi.org/10.5114/ceji.2019.87065 Text en Copyright: © 2019 Polish Society of Experimental and Clinical Immunology http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Clinical Immunology
Makni, Lamia
Zidi, Sabrina
Barbiroud, Mouadh
Ahmed, Amira Ben
Gazouani, Ezzedine
Mezlini, Amel
Stayoussef, Mouna
Yacoubi-Loueslati, Besma
Increased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in Tunisia
title Increased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in Tunisia
title_full Increased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in Tunisia
title_fullStr Increased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in Tunisia
title_full_unstemmed Increased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in Tunisia
title_short Increased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in Tunisia
title_sort increased risks between tlr2 (-196 to -174 ins/del) and tlr3 1377c>t variants and head and neck cancers in tunisia
topic Clinical Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745549/
https://www.ncbi.nlm.nih.gov/pubmed/31530984
http://dx.doi.org/10.5114/ceji.2019.87065
work_keys_str_mv AT maknilamia increasedrisksbetweentlr2196to174insdelandtlr31377ctvariantsandheadandneckcancersintunisia
AT zidisabrina increasedrisksbetweentlr2196to174insdelandtlr31377ctvariantsandheadandneckcancersintunisia
AT barbiroudmouadh increasedrisksbetweentlr2196to174insdelandtlr31377ctvariantsandheadandneckcancersintunisia
AT ahmedamiraben increasedrisksbetweentlr2196to174insdelandtlr31377ctvariantsandheadandneckcancersintunisia
AT gazouaniezzedine increasedrisksbetweentlr2196to174insdelandtlr31377ctvariantsandheadandneckcancersintunisia
AT mezliniamel increasedrisksbetweentlr2196to174insdelandtlr31377ctvariantsandheadandneckcancersintunisia
AT stayoussefmouna increasedrisksbetweentlr2196to174insdelandtlr31377ctvariantsandheadandneckcancersintunisia
AT yacoubiloueslatibesma increasedrisksbetweentlr2196to174insdelandtlr31377ctvariantsandheadandneckcancersintunisia